Uric acid level as a risk marker for metabolic syndrome: A Chinese cohort study

Tsan Yang; Chi Hong Chu; Chyi Huey Bai; San Lin You; Yu Ching Chou; Wan Yun Chou; Kuo Liong Chien; Lee Ching Hwang; Ta Chen Su; Chin Hsiao Tseng; Chien An Sun

doi:10.1016/j.atherosclerosis.2011.11.014

Uric acid level as a risk marker for metabolic syndrome: A Chinese cohort study

Tsan Yang, Chi Hong Chu, Chyi Huey Bai, San Lin You, Yu Ching Chou, Wan Yun Chou, Kuo Liong Chien, Lee Ching Hwang, Ta Chen Su, Chin Hsiao Tseng, Chien An Sun

Research output: Contribution to journal › Article

94 Citations (Scopus)

Abstract

Objective: Despite some epidemiologic research demonstrating a positive relationship between serum uric acid (SUA) levels and the prevalence of metabolic syndrome (MetS), prospective data on SUA as a predictor of MetS incidence are limited. Methods: The authors examined SUA as a risk marker for incident MetS in a prospective study of 3857 subjects who were free of MetS at baseline recruitment. Hyperuricemia was defined as SUA ≥7.7. mg/dL for men and ≥6.6. mg/dL for women. The MetS was defined according to a unified criteria set by several major organizations. Results: During a mean follow-up of 5.41 years, 476 participants developed MetS. A significantly stepwise increase in the incidence of MetS across tertiles of SUA was observed in the whole group (p for trend

Original language	English
Pages (from-to)	525-531
Number of pages	7
Journal	Atherosclerosis
Volume	220
Issue number	2
DOIs	https://doi.org/10.1016/j.atherosclerosis.2011.11.014
Publication status	Published - Feb 2012

Keywords

Cohort study
Hyperuricemia
Metabolic syndrome
Uric acid

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.atherosclerosis.2011.11.014

Fingerprint Dive into the research topics of 'Uric acid level as a risk marker for metabolic syndrome: A Chinese cohort study'. Together they form a unique fingerprint.

Cite this

Yang, T., Chu, C. H., Bai, C. H., You, S. L., Chou, Y. C., Chou, W. Y., Chien, K. L., Hwang, L. C., Su, T. C., Tseng, C. H., & Sun, C. A. (2012). Uric acid level as a risk marker for metabolic syndrome: A Chinese cohort study. Atherosclerosis, 220(2), 525-531. https://doi.org/10.1016/j.atherosclerosis.2011.11.014

@article{cb39750e390149158e941b4c76c2f83b,

title = "Uric acid level as a risk marker for metabolic syndrome: A Chinese cohort study",

abstract = "Objective: Despite some epidemiologic research demonstrating a positive relationship between serum uric acid (SUA) levels and the prevalence of metabolic syndrome (MetS), prospective data on SUA as a predictor of MetS incidence are limited. Methods: The authors examined SUA as a risk marker for incident MetS in a prospective study of 3857 subjects who were free of MetS at baseline recruitment. Hyperuricemia was defined as SUA ≥7.7. mg/dL for men and ≥6.6. mg/dL for women. The MetS was defined according to a unified criteria set by several major organizations. Results: During a mean follow-up of 5.41 years, 476 participants developed MetS. A significantly stepwise increase in the incidence of MetS across tertiles of SUA was observed in the whole group (p for trend ",

keywords = "Cohort study, Hyperuricemia, Metabolic syndrome, Uric acid",

author = "Tsan Yang and Chu, {Chi Hong} and Bai, {Chyi Huey} and You, {San Lin} and Chou, {Yu Ching} and Chou, {Wan Yun} and Chien, {Kuo Liong} and Hwang, {Lee Ching} and Su, {Ta Chen} and Tseng, {Chin Hsiao} and Sun, {Chien An}",

year = "2012",

month = feb,

doi = "10.1016/j.atherosclerosis.2011.11.014",

language = "English",

volume = "220",

pages = "525--531",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Uric acid level as a risk marker for metabolic syndrome

T2 - A Chinese cohort study

AU - Yang, Tsan

AU - Chu, Chi Hong

AU - Bai, Chyi Huey

AU - You, San Lin

AU - Chou, Yu Ching

AU - Chou, Wan Yun

AU - Chien, Kuo Liong

AU - Hwang, Lee Ching

AU - Su, Ta Chen

AU - Tseng, Chin Hsiao

AU - Sun, Chien An

PY - 2012/2

Y1 - 2012/2

N2 - Objective: Despite some epidemiologic research demonstrating a positive relationship between serum uric acid (SUA) levels and the prevalence of metabolic syndrome (MetS), prospective data on SUA as a predictor of MetS incidence are limited. Methods: The authors examined SUA as a risk marker for incident MetS in a prospective study of 3857 subjects who were free of MetS at baseline recruitment. Hyperuricemia was defined as SUA ≥7.7. mg/dL for men and ≥6.6. mg/dL for women. The MetS was defined according to a unified criteria set by several major organizations. Results: During a mean follow-up of 5.41 years, 476 participants developed MetS. A significantly stepwise increase in the incidence of MetS across tertiles of SUA was observed in the whole group (p for trend

AB - Objective: Despite some epidemiologic research demonstrating a positive relationship between serum uric acid (SUA) levels and the prevalence of metabolic syndrome (MetS), prospective data on SUA as a predictor of MetS incidence are limited. Methods: The authors examined SUA as a risk marker for incident MetS in a prospective study of 3857 subjects who were free of MetS at baseline recruitment. Hyperuricemia was defined as SUA ≥7.7. mg/dL for men and ≥6.6. mg/dL for women. The MetS was defined according to a unified criteria set by several major organizations. Results: During a mean follow-up of 5.41 years, 476 participants developed MetS. A significantly stepwise increase in the incidence of MetS across tertiles of SUA was observed in the whole group (p for trend

KW - Cohort study

KW - Hyperuricemia

KW - Metabolic syndrome

KW - Uric acid

UR - http://www.scopus.com/inward/record.url?scp=84855932028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855932028&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2011.11.014

DO - 10.1016/j.atherosclerosis.2011.11.014

M3 - Article

C2 - 22154195

AN - SCOPUS:84855932028

VL - 220

SP - 525

EP - 531

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -